
Insurers and
Lab Partners
PredictSURE IBDâ„¢ is the first validated prognostic test for IBD with measurable economic and health benefits.
How can you help your physicians manage their Crohn’s Disease and ulcerative colitis patients better?
​
How about a first and only prognostic test?
Towards the right treatment, for the right patient, at the right time
​
-
For Crohn’s disease and ulcerative colitis patients
-
Stratify patients into high and low risk of early and frequent flares
-
Exploit the window of opportunity at diagnosis to impact on outcomes
-
High risk patients may benefit from early aggressive therapy